Claims for Patent: 9,408,750

Summary for Patent: 9,408,750

Title:	Reduced-pressure treatment systems and methods employing debridement mechanisms
Abstract:	Reduced-pressure treatment systems and methods are disclosed that employ debridement mechanisms to remove unwanted tissue. In one instance, a reduced-pressure treatment system for treating a tissue site on a patient includes a manifold member for distributing reduced pressure to the tissue site, a support member for disposing proximate the tissue site and the manifold, and a debridement mechanism coupled to the support member. The debridement mechanism is for debriding the tissue site. The system further includes a sealing drape for placing over the tissue site and manifold member. The sealing drape is operable to form a fluid seal over the tissue site and manifold member. The system also includes a reduced-pressure subsystem for delivering a reduced pressure to the sealing drape. The system may further include a chemical-debridement subsystem. Other systems, manifolds, and methods are disclosed.
Inventor(s):	Seegert; Charles Alan (North Richland, TX), Wilkes; Robert Peyton (San Antonio, TX)
Assignee:	KCI Licensing, Inc. (San Antonio, TX)
Application Number:	13/462,817
Patent Claims:	1. A reduced-pressure treatment system for treating a tissue site on a patient, the system comprising: a manifold member adapted to distribute reduced pressure to the tissue site and contract in response to application of reduced pressure to the tissue site; a support member mechanically coupled to the manifold member; a debridement mechanism having a proximal end coupled to the support member and a distal end having at least one cutting edge extending from and operatively coupled to the support member to debride the tissue site, wherein the debridement mechanism is deformable to drive the at least one edge against the undesired tissue in response to contraction of the manifold member when induced by the application of reduced pressure; a sealing drape for placing over the tissue site and manifold member and operable to form a fluid seal over the tissue site and manifold member; a source of reduced-pressure for delivering a reduced pressure through the sealing drape to the manifold member. 2. The system of claim 1, wherein the debridement mechanism comprises a pincer having a first blade and a second blade, each including one of the at least one cutting edges and being movable for debriding the tissue site in response to contraction of the manifold member. 3. The system of claim 2, wherein the first blade and the second blade of the pincer move from an open position to a closed position when the manifold member contracts under the influence of reduced pressure. 4. The system of claim 1, wherein the debridement mechanism comprises a debridement arm having a cutting edge movable for debriding the tissue site in response to contraction of the manifold member. 5. The system of claim 4, wherein the debridement arm deforms to move from a first position to a second position when the manifold member by moving the cutting edge from a first position to a second position. 6. The system of claim 1, further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site. 7. The system of claim 1, further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site, wherein the chemical-debridement subsystem comprises a debriding chemical reservoir in fluid communication with the sealing drape whereby the debriding chemical is delivered to the tissue site. 8. The system of claim 1, further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site, wherein the debriding chemical is one or more enzymes isolated from insect larvae. 9. The system of claim 1, further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site, wherein the debriding chemical is one or more enzymes isolated from insect larvae, and wherein the larvae are larvae from Lucilia sericata. 10. The system of claim 1, further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site, wherein the debriding chemical is one or more synthetic analogues of one or more enzymes isolated from insect larvae. 11. The system of claim 1, further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site, wherein the debriding chemical is one or more synthetic analogues of one or more enzymes isolated from insect larvae, and wherein the larvae are larvae from Lucilia sericata. 12. The system of claim 1, further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site, wherein the debriding chemical is a chemical selected from the group consisting of: collagenase, ficin, pepsin, trypsin, chymotrypsin, papain and elastase. 13. The system of claim 1, wherein the debridement mechanism comprises a jaw formed by two of the at least one blade including a first jaw member and a second jaw member, wherein the first jaw member and second jaw member are operable to move from a first, open position to a second, biting position under the influence of reduced pressure. 14. A manifold member for treating a tissue site on a patient, the manifold member comprising: a manifold material adapted to distribute reduced pressure to the tissue site and contract in response to application of reduced pressure and distribute reduced pressure to the tissue site; a support member mechanically coupled to the manifold material; and a debridement mechanism having a proximal end coupled to the support member and a distal end having at least one cutting edge extending from and operatively coupled to the support member to debride the tissue site, wherein the debridement mechanism is deformable to drive the at least one cutting edge against the undesired tissue in response to contraction of the manifold material when induced by the application of reduced pressure. 15. The manifold member of claim 14, wherein the debridement mechanism comprises a pincer having a first blade and a second blade, each including one of the at least one cutting edges and being movable for debriding the tissue site in response to contraction of the manifold member. 16. The manifold member of claim 15, wherein the first blade and the second blade of the pincer move from an open position to a closed position under the influence of reduced pressure. 17. The manifold member of claim 15, wherein the first blade and the second blade of the pincer move from an open position to a closed position under the influence of reduced pressure, and wherein the first blade and the second blade of the pincer move from a closed position to a collapsed position under the influence of additional reduced pressure.

Details for Patent 9,408,750

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2039-02-26